Medicine Description levemir 100i
Levemir 100 IU Insulin Pen is a medication that contains insulin detemir, a long-acting insulin analog. Its pharmacological effect is derived from its ability to mimic the natural insulin produced by the pancreas, which is crucial for facilitating the transport of glucose into cells. Insulin detemir interacts with insulin receptors on target cells, leading to increased glucose uptake, reduced hepatic glucose production, and enhanced peripheral utilization of glucose. The extended duration of action is attributed to its unique fatty acid side chain, which promotes albumin binding. This binding results in a slow release of insulin into the bloodstream, providing a consistent and prolonged effect that helps stabilize blood glucose levels over an extended period.
Indications and Uses of Levemir 100 IU Insulin Pen
- Management of diabetes mellitus in adults and children requiring long-acting insulin therapy
- Improvement of glycemic control in individuals with type 1 diabetes
- Improvement of glycemic control in individuals with type 2 diabetes
Side Effects of Levemir 100 IU Insulin Pen
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling, itching)
- Weight gain
- Allergic reactions (rare)
- Skin changes (lipodystrophy)
Storage and Handling
Store Levemir at a temperature between 36°F to 46°F (2°C to 8°C). Protect from light and do not freeze. Once in use, it can be stored at room temperature (up to 86°F or 30°C) for up to 42 days. Discard any unused insulin pen after this period.
Patient Advice and Precautions
Monitor blood glucose levels regularly to ensure effective diabetes management. Rotate injection sites to minimize skin reactions and consider using a sharps container for safe disposal of used needles. Inform your healthcare provider if you experience symptoms of hypoglycemia or if you are pregnant, planning to become pregnant, or breastfeeding.